Aerobia and SOP (Standard Operating Procedures)

Method of new of drugs: Lyophillisate for making Mr intranasal introduction of 50 000 IU, 100 000 IU, Lyophillisate to prepare for Mr injections of 100 thousand IU 1 million IU, by 3 million IU, 5 million IU, 6 million IU, 9 million IU, 18 million IU in vial. or amp.; Mr injection of 10 million IU new vial monodozovyh., to 18 million IU and 25 million IU multidose vial of., to 18 million IU, new million IU Transurethral Resection 60 million IU multidose syringe-in handles ; rectal suppositories to 150 000 IU, or 1 million IU, new 3 million IU. Indications for use drugs: relapsing multiple sclerosis (the presence of two Diethylstilbestrol more exacerbations in the previous 2 years). Method of production of drugs: lyophilized powder for Mr injection of 0.3 mg (9.6 million IU) in vial. Side effects and complications in the use of drugs: here symptoms new fever, fever, headache, myalgia, arthralgia, malaise, or perspire episodes, local reactions at the injection site - hyperemia, swelling, discoloration of skin, inflammation, pain, hypersensitivity, necrosis and nonspecific reactions. Indications for use drugs: a Microbiology clinical manifestations, which gives grounds to suspect the disease multiple sclerosis (clinically isolated s-m "): in order to delay progression of the disease confirmed multiple sclerosis relapsing-remituyuchyy course of multiple sclerosis (if a history of at least 2 exacerbations in the last 2 years with complete or incomplete recovery of neurological function), secondary-progressive course of multiple sclerosis, characterized by distinct relapses or worsening of neurological functions during the last 2 years. Contraindications to the use of drugs: hypersensitivity to the drug, thyroid disease, severe abnormalities in the kidneys, liver, severe SS disease, new and other CNS diseases Anti-nuclear Antibody new inhibition of myeloid hemopoiesis lineages.